Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

BI-10773 improves glycemic control in large study in type 2 diabetes

Sep. 27, 2010

Novartis reports on clinical development of LDE-225

Sep. 27, 2010

Interim phase I/II data suggest safety of everolimus in advanced HCC

Sep. 27, 2010

Phase I data presented on hypnotic agent GF-015535-00

Sep. 27, 2010

New vancomycin carbamate derivative shows potent antibacterial activity in drug-resistant strains

Sep. 23, 2010

Favorable safety and pharmacokinetics seen in phase I trials of anti-CMV agent AIC-246

Sep. 23, 2010

Multiple dosing of AMG-853 well tolerated in healthy volunteers

Sep. 23, 2010

High loading dose of clopidogrel may overcome effects of CYP2C19 genetic variant in persons with CAD

Sep. 23, 2010

Fixed-dose fenofibrate/pravastatin plus ezetimibe reduces hyperlipidemia in type 2 diabetes

Sep. 23, 2010

First selective Aurora kinase A inhibitors identified

Sep. 23, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...